Neurones (NE9) Financial Statements
Neurones Financial Overview
Neurones's market cap is currently $907.21M. The company's EPS TTM is $2.28; its P/E ratio is 16.69; and it has a dividend yield of 3.73%. Neurones has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 857.20M | $ 810.40M | $ 741.17M | $ 665.38M | $ 579.88M |
| Gross Profit | $ 90.04M | $ 388.76M | $ 346.76M | $ 81.64M | $ 69.73M |
| Operating Income | $ 72.33M | $ 77.90M | $ 75.86M | $ 72.89M | $ 61.57M |
| EBITDA | $ 90.32M | $ 95.56M | $ 96.63M | $ 88.72M | $ 76.33M |
| Net Income | $ 52.07M | $ 52.50M | $ 49.41M | $ 44.24M | $ 37.71M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 340.78M | $ 326.49M | $ 297.76M | $ 272.06M | $ 265.17M |
| Total Assets | $ 749.03M | $ 725.69M | $ 674.25M | $ 616.22M | $ 567.82M |
| Total Debt | $ 36.96M | $ 42.02M | $ 43.98M | $ 35.57M | $ 35.32M |
| Net Debt | $ -303.82M | $ -284.47M | $ -253.78M | $ -236.49M | $ -229.85M |
| Total Liabilities | $ 284.16M | $ 289.52M | $ 266.34M | $ 240.63M | $ 214.90M |
| Stockholders' Equity | $ 399.98M | $ 378.10M | $ 354.39M | $ 330.58M | $ 311.56M |
| Cash Flow | |||||
| Free Cash Flow | $ 70.33M | $ 72.34M | $ 54.09M | $ 44.33M | $ 58.10M |
| Operating Cash Flow | $ 80.77M | $ 84.38M | $ 72.08M | $ 54.97M | $ 64.50M |
| Investing Cash Flow | $ -21.16M | $ -19.69M | $ -21.57M | $ -12.26M | $ -10.62M |
| Financing Cash Flow | $ -45.11M | $ -34.48M | $ -27.06M | $ -36.08M | $ -55.42M |
Currency in EUR